Pasithea Therapeutics (KTTA) Stock Chart & Stock Price History $1.38 +0.01 (+0.73%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$1.38 0.00 (-0.36%) As of 04/17/2025 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Pasithea Therapeutics Stock Price Performance 5 Day Performance+4.55%1 Month Performance+16.95%3 Month Performance-44.35%6 Month Performance-68.06%Year-To-Date Performance-56.19%1 Year Performance-80.59% Receive KTTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address KTTA Stock Chart for Sunday, April, 20, 2025 KTTA Chart by TradingView Pasithea Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2025$1.38$1.38$1.47$1.33113,976 shs$3.73 million04/17/2025$1.37$1.38+0.73%$1.47$1.33113,976 shs$3.73 million04/16/2025$1.32$1.37+3.79%$1.53$1.24291,584 shs$3.71 million04/15/2025$1.18$1.32+11.86%$1.40$1.15332,815 shs$3.57 million04/14/2025$1.42$1.18-16.90%$1.48$1.13634,853 shs$3.19 million04/11/2025$1.60$1.42-11.25%$1.70$1.401.67 million shs$3.84 million04/10/2025$1.09$1.60+46.79%$2.34$1.42101.31 million shs$4.33 million04/09/2025$1.19$1.09-8.40%$1.16$1.0490,584 shs$2.95 million04/09/2025$1.19$1.09-8.40%$1.16$1.0490,584 shs$2.95 million04/08/2025$1.21$1.19-1.65%$1.23$1.1634,874 shs$3.22 million Get the Latest News and Ratings for KTTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/08/2025$1.21$1.19-1.65%$1.23$1.1634,874 shs$3.22 million04/07/2025$1.27$1.21-4.72%$1.25$1.1531,956 shs$3.27 million04/04/2025$1.27$1.27$1.27$1.2032,832 shs$3.44 million04/03/2025$1.19$1.27+6.72%$1.29$1.1495,730 shs$3.44 million04/02/2025$1.24$1.19-4.03%$1.26$1.1825,154 shs$3.22 million04/01/2025$1.30$1.24-4.62%$1.33$1.2324,936 shs$3.35 million03/31/2025$1.34$1.30-2.99%$1.34$1.13189,889 shs$3.52 million03/28/2025$1.32$1.34+1.52%$1.39$1.2550,339 shs$1.70 million03/27/2025$1.38$1.32-4.35%$1.35$1.3234,298 shs$1.67 million03/26/2025$1.25$1.38+10.40%$1.39$1.2676,835 shs$1.75 million03/25/2025$1.25$1.25$1.32$1.2266,239 shs$1.58 million03/24/2025$1.24$1.25+0.81%$1.33$1.1761,129 shs$1.58 million03/21/2025$1.18$1.24+5.08%$1.24$1.1256,658 shs$1.57 million03/20/2025$1.15$1.18+2.61%$1.19$1.1321,375 shs$1.49 million03/19/2025$1.09$1.15+5.50%$1.18$1.0634,899 shs$1.46 million Related Companies NeuroSense Therapeutics Stock Price Chart Bullfrog AI Stock Price Chart BioVie Stock Price Chart BioAtla Stock Price Chart MEI Pharma Stock Price Chart ImmunoPrecise Antibodies Stock Price Chart Cocrystal Pharma Stock Price Chart IN8bio Stock Price Chart Imunon Stock Price Chart iBio Stock Price Chart Receive KTTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KTTA) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pasithea Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pasithea Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
